1. Home
  2. KYMR vs CART Comparison

KYMR vs CART Comparison

Compare KYMR & CART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

SELL

Current Price

$106.49

Market Cap

9.1B

Sector

Health Care

ML Signal

SELL

Logo Maplebear Inc.

CART

Maplebear Inc.

SELL

Current Price

$49.34

Market Cap

10.5B

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
KYMR
CART
Founded
2015
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
10.5B
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
KYMR
CART
Price
$106.49
$49.34
Analyst Decision
Strong Buy
Buy
Analyst Count
24
32
Target Price
★ $139.35
$58.21
AVG Volume (30 Days)
791.6K
★ 3.6M
Earning Date
11-03-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1.27
EPS
N/A
★ 1.02
Revenue
$39,211,000.00
★ $3,742,000,000.00
Revenue This Year
$167.23
$13.77
Revenue Next Year
N/A
$10.54
P/E Ratio
★ N/A
$48.68
Revenue Growth
N/A
★ 10.78
52 Week Low
$55.26
$32.73
52 Week High
$130.05
$52.68

Technical Indicators

Market Signals
Indicator
KYMR
CART
Relative Strength Index (RSI) 40.87 63.41
Support Level $100.63 $42.13
Resistance Level $121.24 $51.93
Average True Range (ATR) 5.07 1.20
MACD -0.31 0.74
Stochastic Oscillator 36.08 87.99

Price Performance

Historical Comparison
KYMR
CART

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

About CART Maplebear Inc.

Maplebear (Instacart) is a grocery-focused delivery marketplace that connects national and regional grocers with consumers and couriers, and consumers with their favorite stores. Its app provides on-demand convenience for consumers, lets couriers earn income, and helps grocers scale through digital channels. The marketplace gathers valuable consumer behavior data, attracting consumer-packaged-goods advertisers that seek to reach consumers at the point of purchase. With approximately 600,000 shoppers and 2,200 retail partners, Instacart delivers to about 98% of households in the United States and Canada.

Share on Social Networks: